Compare CLMB & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLMB | LAB |
|---|---|---|
| Founded | 1982 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 436.8M | 488.4M |
| IPO Year | 1996 | 2008 |
| Metric | CLMB | LAB |
|---|---|---|
| Price | $87.04 | $1.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $136.00 | $1.35 |
| AVG Volume (30 Days) | 54.9K | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | 14.29 | ★ 44.68 |
| EPS | ★ 4.64 | N/A |
| Revenue | ★ $652,517,000.00 | $101,937,000.00 |
| Revenue This Year | $2.60 | N/A |
| Revenue Next Year | $1.93 | N/A |
| P/E Ratio | $19.23 | ★ N/A |
| Revenue Growth | ★ 40.14 | N/A |
| 52 Week Low | $80.08 | $0.92 |
| 52 Week High | $145.00 | $1.72 |
| Indicator | CLMB | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 25.92 | 29.04 |
| Support Level | N/A | $0.95 |
| Resistance Level | $112.37 | $1.41 |
| Average True Range (ATR) | 6.98 | 0.07 |
| MACD | -3.34 | -0.00 |
| Stochastic Oscillator | 17.52 | 4.44 |
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.